With the close of the expedited review application window on November 17, 2023, the standard review period on December 18, 2023, and the resolution of the lawsuit that stalled the CAURD program, many thought that the hard work was behind them. But the reality is that for New York applicants, the hard work continues, and for many, the hard work has just begun. With ongoing additional entity and personal disclosures, deficiencies and cures, and site control perfection and local approvals, in many respects, application submittal was just the tip of the iceberg. Foley Hoag’s New York Cannabis Application team delved into its 2023 post-mortem, next steps, and other issues facing this ever evolving marketplace, including:
- Application Window in Review: A look at the numbers.
- What is required as part of my post-submittal entity and personal TPI disclosures?
- What are some of the types of deficiencies and timelines for cure?
- Post-Selection Application Process: I won a license, what happens next and how can I open my business?
- What types of questions and/or issues am I likely to face as I’m called before a municipal or NYC community board?
- What is the impact of the initial CAURD settlement and subsequent litigation?
- When will application rounds open up again for what license classes?
Hear from Foley Hoag’s team of professionals who have assisted and worked with every type of medical and adult-use license issued by the State of New York to date (ROs, AUCCs, AUCPs, RODs, CAURDs, and regular and provisional retailers) as we walk through what promises to be a busy 2024 in New York Cannabis.
